Results 221 to 230 of about 171,326 (357)

Efficacy of Anti-D Immunoglobulin (Anti-D) and Intravenous Immunoglobulin(IVIg) in the Treatment of Acute Immune Thrombocytopenic Purpura (ITP) in Children. † 665 [PDF]

, 1997
Reneé M. Madden, Salvatore Bertolone, Ronald M. Kline, Chandrakant C. Patel, Cynthia E. Gonzales, D.Lucille Fennewald, Michael D. Tarantino   +6 more
openalex   +1 more source

Comparison of intravenous efgartigimod and intravenous immunoglobulin in patients with Guillain-Barré syndrome. [PDF]

Orphanet J Rare Dis
Zhang H, Zhai F, Su M, Zhang Y, Ma J, Zhao J, Wang J, Chang X, Liu Y, Guo J, Zhang W.   +10 more
europepmc   +1 more source

Efficacy, safety and cost‐effectiveness of CAR‐T therapy

British Journal of Clinical Pharmacology, EarlyView.
CAR T‐cells demonstrate high efficacy in blood cancers, including ALL, MM and DLBCL. Innovations target solid tumours despite challenges such as antigen escape. Combination therapies enhance the delivery and infiltration of CAR T cells. Toxicity, cost and resistance remain major barriers to clinical use.
Emina Karahmet Sher, Amina Džidić‐Krivić, Emma Pinjic, Nejra Selak, Kanita Omerbasic, Alexandar Chupin, Andrej Belancic, Almir Fajkic   +7 more
wiley   +1 more source

Haemolytic Anaemia Following High Dose Intravenous Immunoglobulin Treatment for Epidermolysis Bullosa Acquisita

, 2016
Sarah Madeline Brown, Philip Hampton
openalex   +2 more sources

Use of Intravenous Immunoglobulin in Critically Ill Patients [PDF]

, 2014
Summer Donovan, Gonzalo Bearman
openalex   +1 more source

The influence of early intravenous immunoglobulin administration on the prognosis of severe hemolytic disorders in neonates. [PDF]

BMC Pediatr
Zhu D, Zhou Q, Yu B, Chen C.
europepmc   +1 more source

Carrier‐free self‐assembled nanomedicine for combination‐therapy of acute myeloid leukemia

BMEMat, EarlyView.
CPDS combines drugs with three different mechanisms of action to achieve a multi‐mechanism combination therapy for AML by directly killing tumor cells and activating anti‐tumor immunity. Abstract As the main acute myeloid leukemia (AML) clinical treatment, the chemotherapy alone cannot meet the clinical therapeutic needs due to the high heterogeneity ...
Meihong Chai, Rui Zhang, Haiyin Yang, Jiyue Xing, Tianyuan Hu, Mengxi Zhu, Rui Li, Xiaoli Chen, Beibei Zhao, Yang Lan, Stefan Barth, Yuanyu Huang, Li Zhang, Mengjie Zhang, Huining He   +14 more
wiley   +1 more source

USE OF INTRAVENOUS IMMUNOGLOBULIN WITHIN THE IVF/ICSI PROTOCOL IN WOMEN WITH INFERTILITY AND ANTIPHOSPHOLIPID ANTIBODIES

, 2017
M. I. Krivonos, М. С. Зайнулина, Ekaterina A. Kornyushina, S. V. Chepanov, S. А. Selkov   +4 more
openalex   +2 more sources

Real time in vivo efficacy monitoring of desialylation and perforation enhanced immunotherapy of cancer

BMEMat, EarlyView.
A multifunctional nanomedicine is designed to engineer NK cells for enhanced cancer immunotherapy through perforation and desialylation, enabling real‐time monitoring of ATP and GrB levels for precise efficacy assessment. Abstract Efficient enhanced NK cell therapy is of critical importance in the immune treatment of cancer.
Yuanjiao Yang, Yuru Wang, Xuemei Li, Chaoyi Yang, Yuhui Yang, Yanyun Fang, Lin Ding, Yunlong Chen, Huangxian Ju   +8 more
wiley   +1 more source

Clinical Images: Sevoflurane‐induced periostitis

Arthritis &Rheumatology, EarlyView.
Christian Beyer, Marion Ganslmayer, Richard Strauß, Bernhard Manger   +3 more
wiley   +1 more source